Bioventure hub blir dubbelt så stort

Life science-företagsparken i Astrazenecas lokaler i Mölndal fördubblar sin yta.

Fewer visitors but satisfied exhibitors

Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.

Double the channels for half the work

The 16-well pipettes from Capp cause less strain for the user when setting up a 384-well plate.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala....

Bio-Linux goes global

Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.

Einar Pontén, Managing Director, Merck Sequant

Why are you going to Scanlab+Biotech Forum?

Product Specialist at Gradientech AB, Uppsala

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

They’re all doing it – buying drug research

It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.

Samuel Lagercrantz: Collaboration and joint efforts are the key to success

Although many questions about Covid-19 remain unanswered, the development of drugs and vaccines has been incredibly rapid, writes Samuel Lagercrantz, Life Scien...

Globalt uttalande

Pfizers globala uttalande efter patentgodkännande av Prevenar 13 i Indien.

Hormones make children fat

A new Danish million project will define the connection between hormons and obesity amongst children.

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Nya resultat om immunförsvarets reaktion vid svår covid-19

Forskare har identifierat flera celltyper som är centrala vid immunförsvarets reaktion vid covid-19.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

An industry emerging from crisis

"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

”Sverige klarar tillverkningen”

I Matfors bygger Cobra Biologics två unika tillverkningssviter för storskalig GMP-tillverkning av ATMP-produkter. Kontraktstillverkaren rustar för att möta den ...

Future drugs from Amaryllis

A Danish research team has discovered possibolities to extract drugs fro Amaryllis.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Uppsving för Pandemifonden: ”Förut ville ingen lyssna”

Virologiprofessorn Niklas Arnberg pratar om smittspridning, punk och vaccinskepticism med Life Science Sweden, men framförallt om Pandemifonden som ska få Sveri...

Samuel Lagercrantz: Framgången kommer efter många misslyckanden

De allra flesta av de idéer och strategier mot covid-19 som man nu jobbar med kommer att gå i stöpet, men det kan räcka med att en enda fungerar, skriver Samuel Lagercrantz.